Erste Asset Management GmbH increased its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 6.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,690,449 shares of the company's stock after purchasing an additional 104,989 shares during the quarter. Erste Asset Management GmbH owned approximately 0.79% of Bath & Body Works worth $51,282,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently made changes to their positions in BBWI. Victory Capital Management Inc. lifted its stake in shares of Bath & Body Works by 14,732.0% in the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock valued at $206,119,000 after purchasing an additional 6,752,274 shares during the period. D1 Capital Partners L.P. purchased a new position in shares of Bath & Body Works in the 4th quarter valued at approximately $109,797,000. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Bath & Body Works by 115.7% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company's stock valued at $111,581,000 after purchasing an additional 1,973,679 shares during the period. Assenagon Asset Management S.A. lifted its stake in shares of Bath & Body Works by 3,642.2% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock valued at $50,062,000 after purchasing an additional 1,606,988 shares during the period. Finally, Anomaly Capital Management LP lifted its stake in shares of Bath & Body Works by 38.3% in the 4th quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company's stock valued at $188,456,000 after purchasing an additional 1,346,752 shares during the period. Hedge funds and other institutional investors own 95.14% of the company's stock.
Bath & Body Works Stock Performance
Shares of BBWI stock traded up $1.6350 during mid-day trading on Friday, hitting $31.0550. The company's stock had a trading volume of 4,792,107 shares, compared to its average volume of 4,610,963. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87. The business has a 50-day moving average price of $30.30 and a 200 day moving average price of $30.97. The stock has a market cap of $6.57 billion, a price-to-earnings ratio of 8.28, a PEG ratio of 1.04 and a beta of 1.54.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The firm had revenue of $1.40 billion during the quarter, compared to analysts' expectations of $1.42 billion. During the same quarter in the previous year, the business earned $0.38 earnings per share. The company's revenue was up 2.9% on a year-over-year basis. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. Equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be paid a $0.20 dividend. The ex-dividend date is Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.6%. Bath & Body Works's payout ratio is currently 21.33%.
Wall Street Analyst Weigh In
BBWI has been the subject of a number of research analyst reports. Morgan Stanley lowered their target price on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research note on Tuesday, May 6th. The Goldman Sachs Group lowered their price objective on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research note on Friday, May 30th. Citigroup lowered their price objective on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a research note on Tuesday, August 19th. Wells Fargo & Company lifted their price objective on Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, May 14th. Finally, Piper Sandler set a $39.00 price objective on Bath & Body Works and gave the company an "overweight" rating in a research note on Thursday, May 15th. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $42.06.
Get Our Latest Stock Analysis on BBWI
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.